Management of Myeloproliferative Neoplasms: From Academic Guidelines to Clinical Practice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Myeloproliferative Neoplasms: From Academic Guidelines to Clinical Practice
Authors
Keywords
-
Journal
Current Hematologic Malignancy Reports
Volume 7, Issue 1, Pages 50-56
Publisher
Springer Nature
Online
2012-01-25
DOI
10.1007/s11899-011-0109-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Annual Clinical Updates in Hematological Malignancies: A Continuing Medical Education Series: Polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management
- (2011) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- Comparison of thalidomide and lenalidomide as therapy for myelofibrosis
- (2011) E. Jabbour et al. BLOOD
- Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis
- (2011) H. J. Deeg et al. BLOOD
- Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- New mutations and pathogenesis of myeloproliferative neoplasms
- (2011) W. Vainchenker et al. BLOOD
- Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
- (2011) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980
- (2011) Jean-Jacques Kiladjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903
- (2010) R. A. Mesa et al. BLOOD
- Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
- (2010) A. Alvarez-Larran et al. BLOOD
- Guideline for investigation and management of adults and children presenting with a thrombocytosis
- (2010) Claire N. Harrison et al. BRITISH JOURNAL OF HAEMATOLOGY
- A phase-2 trial of low-dose pomalidomide in myelofibrosis
- (2010) K H Begna et al. LEUKEMIA
- Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients
- (2010) F Girodon et al. LEUKEMIA
- A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications
- (2010) F Passamonti et al. LEUKEMIA
- MPN-associated myelofibrosis (MPN-MF)
- (2010) R.A. Mesa et al. LEUKEMIA RESEARCH
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
- (2009) N. Kroger et al. BLOOD
- Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
- (2009) F. P. S. Santos et al. BLOOD
- Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type
- (2009) A Bacigalupo et al. BONE MARROW TRANSPLANTATION
- Allogeneic hematopoietic cell transplantation for patients with myelofibrosis
- (2009) Dae Young Zang et al. CURRENT OPINION IN HEMATOLOGY
- Lenalidomide Plus Prednisone Results in Durable Clinical, Histopathologic, and Molecular Responses in Patients With Myelofibrosis
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis
- (2009) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
- (2008) F. Cervantes et al. BLOOD
- Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain
- (2008) P. D. Ziakas HAEMATOLOGICA
- Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia
- (2008) Alessandra Carobbio et al. JOURNAL OF CLINICAL ONCOLOGY
- 5-Azacitidine has limited therapeutic activity in myelofibrosis
- (2008) R A Mesa et al. LEUKEMIA
- Is JAK2 V617F mutation more than a diagnostic index?
- (2008) Issa J. Dahabreh et al. LEUKEMIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started